tiprankstipranks
Trending News
More News >
BioRestorative Therapies (BRTX)
NASDAQ:BRTX
US Market

BioRestorative Therapies (BRTX) Income Statement

Compare
210 Followers

BioRestorative Therapies Income Statement

Last quarter (Q3 2025), BioRestorative Therapies's total revenue was $11.80K, a decrease of -72.75% from the same quarter last year. In Q3, BioRestorative Therapies's net income was $-3.04M. See BioRestorative Therapies’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 401.00K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Gross Profit
$ 372.93K$ 145.80K$ 119.80K$ 46.00K$ 77.00K
Operating Expenses
$ 11.93M$ 15.37M$ 19.09M$ 26.35M$ 2.83M
Depreciation and Amortization
$ 189.06K$ 165.74K$ 120.55K$ 89.11K$ 151.96K
EBITDA
$ -11.37M$ -14.97M$ -18.74M$ -26.22M$ -9.48M
Operating Income
$ -11.56M$ -15.22M$ -18.97M$ -26.31M$ -2.75M
Other Income/Expenses
$ 2.58M$ 4.80M$ 5.75M$ -18.00M$ -8.52M
Pretax Income
$ -8.98M$ -10.42M$ -13.22M$ -44.30M$ -11.27M
Net Income
$ -8.98M$ -10.42M$ -13.22M$ -44.30M$ -11.27M
Per Share Metrics
Basic EPS
$ -1.16$ -2.47$ -3.65$ -37.30$ -28.56
Diluted EPS
$ -1.16$ -2.47$ -3.65$ -37.30$ -28.56
Weighted Average Shares Outstanding
7.76M 4.22M 3.62M 1.19M 394.70K
Weighted Average Shares Outstanding (Diluted)
7.76M 4.22M 3.62M 1.19M 394.70K
Currency in USD

BioRestorative Therapies Earnings and Revenue History